Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
10.1038/s41467-022-33598-x 22 LiuL.YaqinW.SergioG.HeQ.XiaS
Effect of liraglutide combined with metformin or acarbose on glucose control in type 2 diabetes mellitus and risk factors of gastrointestinal adverse reactions
Provides assistance to the family dealing with the long-term care of a child with chronic illness
N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Interestingly, the result was independent of changes in BMI and HbA1c, showing that, mechanistically, it was related to mechanisms beyond weight loss and improved glycemic control
US$ 24.01
US$ 25.86
US$ 28.66
